Multiple HIV-1-specific IgG3 responses decline during acute HIV-1
- 13 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 25 (17), 2089-2097
- https://doi.org/10.1097/qad.0b013e32834b348e
Abstract
Objective: Different HIV-1 antigen specificities appear in sequence after HIV-1 transmission and the immunoglobulin G (IgG) subclass responses to HIV antigens are distinct from each other. The initial predominant IgG subclass response to HIV-1 infection consists of IgG1 and IgG3 antibodies with a noted decline in some IgG3 antibodies during acute HIV-1 infection. Thus, we postulate that multiple antigen-specific IgG3 responses may serve as surrogates for the relative time since HIV-1 acquisition. Design: We determined the magnitude, peak, and half-life of HIV-1 antigen-specific IgG1 and IgG3 antibodies in 41 HIV-1-infected individuals followed longitudinally from acute infection during the first appearance of HIV-1-specific antibodies through approximately 6 months after infection. Methods: We used quantitative HIV-1-binding antibody multiplex assays and exponential decay models to estimate concentrations of IgG1 and IgG3 antibodies to eight different HIV-1 proteins including gp140 Env, gp120 Env, gp41 Env, p66 reverse transcriptase, p31 Integrase, Tat, Nef, and p55 Gag proteins during acute/recent HIV-1 infection. Results: Among HIV-1-specific IgG3 responses, anti-gp41 IgG3 antibodies were the first to appear. We found that anti-gp41 Env IgG3 and anti-p66 reverse transcriptase IgG3 antibodies, in addition to anti-Gag IgG3 antibodies, each consistently and measurably declined after acute infection, in contrast to the persistent antigen-specific IgG1 responses. Conclusion: The detailed measurements of the decline in multiple HIV-specific IgG3 responses simultaneous with persistent IgG1 responses during acute and recent HIV-1 infection could serve as markers for detection of incident HIV infection.Keywords
This publication has 29 references indexed in Scilit:
- Development and Characterization of a Bead-Based, Multiplex Assay for Estimation of Recent HIV Type 1 InfectionAIDS Research and Human Retroviruses, 2012
- Effect of CD4+ T Cell Count and Antiretroviral Treatment on Two Serological HIV Incidence AssaysAIDS Research and Human Retroviruses, 2012
- The immune response during acute HIV-1 infection: clues for vaccine developmentNature Reviews Immunology, 2009
- Augmented Cross‐Sectional Prevalence Testing for Estimating HIV IncidenceBiometrics, 2009
- HIV-1-specific antibody responses during acute and chronic HIV-1 infectionCurrent Opinion in HIV and AIDS, 2009
- Assessment of the Ability of a Fourth-Generation Immunoassay for Human Immunodeficiency Virus (HIV) Antibody and p24 Antigen To Detect both Acute and Recent HIV Infections in a High-Risk SettingJournal of Clinical Microbiology, 2009
- Polyclonal B Cell Differentiation and Loss of Gastrointestinal Tract Germinal Centers in the Earliest Stages of HIV-1 InfectionPLoS Medicine, 2009
- Errors in ‘BED’-Derived Estimates of HIV Incidence Will Vary by Place, Time and AgePLOS ONE, 2009
- Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial ViremiaJournal of Virology, 2008
- A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1Science, 2007